Centrexion Therapeutics stock hits 52-week low at $0.55 View all comments (0) 0 Latest comments Post Comment Guidelines Trade With A Regulated Broker Indices Commodities Bonds Stocks US 30 42,045. ...

In a challenging year for Centrexion Therapeutics Corp, the biopharmaceutical company’s stock has tumbled to a 52-week low, touching down at $0.55. Despite the current market pressure ...

In a challenging year for Centrexion Therapeutics Corp, the biopharmaceutical company’s stock has tumbled to a 52-week low, touching down at $0.55. Despite the current market pressure, InvestingPro ...

Eli Lilly has signed another bolt-on deal to bulk up its pipeline, this time paying $47.5 million upfront for rights to a non-opioid analgesic drug developed by US biotech Centrexion Therapeutics.

In 2013, two years after leaving Pfizer, Kindler became CEO of Centrexion Therapeutics, a Boston-based company focused on using non-opioid products to ease chronic pain. Kindler still holds the ...

Google’s new ‘G’ logo appeared on stage during the I/O 2025 keynote, and is now live in more apps and the web. The new logo made its debut with the Google app on Android and iOS last week.

Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal ...

OKLAHOMA CITY — As Game 1 of the NBA Finals began at Paycom Center, discerning fans on social media asked: “Why aren’t there NBA Finals logos on the court?” For the most part – there are ...

Orlando has brought back a version of its classic logo and showed off 3 new uniform looks for next season. Official release Franz Wagner, Jalen Suggs and Paolo Banchero model some of the Magic’s ...

Shares of Summit Therapeutics (NASDAQ: SMMT) have plunged 31% as of 1:23 p.m. ET Friday, following the release of some trial data this morning. Summit has been a tremendous winner over the past ...